SELEC.E
vs
BIST 100
Over the past 12 months, SELEC.E has outperformed BIST 100, delivering a return of 35% compared to the BIST 100's 27% growth.
Stocks Performance
SELEC.E vs BIST 100
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
IT |
Amplifon SpA
MIL:AMP
|
Performance Gap
SELEC.E vs BIST 100
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
IT |
Amplifon SpA
MIL:AMP
|
Performance By Year
SELEC.E vs BIST 100
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Mckesson Corp
NYSE:MCK
|
||
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
IT |
Amplifon SpA
MIL:AMP
|
Competitors Performance
Selcuk Ecza Deposu Ticaret ve Sanayi AS vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
MX |
M
|
Mexico S&P/BMV IPC
INDX:MXX
|
|
PK |
K
|
Karachi 100
INDX:KSE100
|
|
SA |
T
|
Tadawul All Share
INDX:TASI
|
|
TH |
S
|
SET Index
INDX:SET
|
|
ID |
J
|
Jakarta Composite Index
INDX:JKSE
|
|
GR |
A
|
Athens General Composite
INDX:ATG
|
|
BR |
B
|
BOVESPA
INDX:BVSP
|
|
AR |
S
|
S&P Merval
INDX:MERV
|
|
CZ |
P
|
PX Prague Stock Index
INDX:PX
|
|
RU |
M
|
MOEX Russia
INDX:IMOEX
|
Selcuk Ecza Deposu Ticaret ve Sanayi AS
Glance View
In the dynamic landscape of Turkey's pharmaceutical industry, Selçuk Ecza Deposu Ticaret ve Sanayi A.Ş. stands as a formidable force, deftly operating as a bridge between pharmaceutical manufacturers and healthcare providers. Established in 1958, the company has cultivated an extensive distribution network that covers the length and breadth of Turkey. With a meticulously coordinated logistics framework, Selçuk Ecza ensures that a vast array of pharmaceutical products—from essential medicines to specialized healthcare solutions—reach pharmacies, hospitals, and healthcare institutions efficiently. This seamless operation is buoyed by the company’s ability to adapt to the ever-changing regulatory environment and consumer demands, thereby ensuring its relevance in the market for decades. The essence of Selçuk Ecza’s business model lies in its comprehensive approach to distribution, where it capitalizes on economies of scale to ensure cost-effectiveness while maintaining high-quality service standards. Revenue is generated primarily through the sales margins on the wide range of pharmaceuticals it distributes. The company’s proficiency in maintaining robust relationships with global pharmaceutical giants and local suppliers alike underpins its substantial market share. Furthermore, by embracing technological advancements, such as real-time inventory management systems, Selçuk Ecza optimizes its supply chain operations, minimizing delays and maximizing efficiency. This strategic prowess not only cements its position as a leading distributor in Turkey but also fosters sustainable growth by continuously aligning with the dynamic healthcare industry.